US2014107163A1PendingUtilityA1

Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine

54
Assignee: TARGECEPT INCPriority: Dec 1, 2008Filed: Dec 16, 2013Published: Apr 17, 2014
Est. expiryDec 1, 2028(~2.3 yrs left)· nominal 20-yr term from priority
Inventors:Srinvasa Rao AkireddyScott R. BreiningTimothy J. CuthbertsonGary Maurice DullGregory J. GattoJohn GenusPhillip S. HammondJoseph Pike Mitchener, Jr.Julio A. MunozPieter Albert OttenDaniel YohannesNikolai Fedorov
A61P 37/06A61P 3/00A61P 29/00A61P 25/00A61P 31/12A61P 25/18A61P 25/28A61P 25/04A61P 31/04C07D 405/14A61K 31/4439C07D 207/08A61K 31/40
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine, its salt forms, and to processes for the commercial-scale production of these compounds in sufficient purity and quality for use in pharmaceutical compositions.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An administration regimen of a pharmaceutical composition comprising administering (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine, or a pharmaceutically acceptable salt thereof in amounts of between 7 to 2200 μg/kg.

Join the waitlist — get patent alerts

Track US2014107163A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.